An $18 billion settlement offer from three major drug wholesalers aimed at resolving litigation over their alleged role in the opioid crisis appears to have fallen apart, after more than 20 state attorneys general rejected it in a letter sent to the companies law firms this week.
The letter, reviewed by The Wall Street Journal, shows that the drug industry hasnt won enough support from states to begin moving the sprawling litigation to a global resolution.